Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone plus Statins in AEH and EEC
NCT06102863Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2023
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Atypical endometrial hyperplasia (AEH) and endometrial carcinoma (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Pathological cumulative complete response rate at 7 months. Started Apr 2023; status: recruiting.
02
Conditions
Atypical endometrial hyperplasia (AEH)endometrial carcinoma
Beyond the preview
Go deeper on NCT06102863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06102863.